Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 14/20 | 0.77 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | TOP2A | P11388 | 2/20 | 0.45 |
| ▸ | TOP2B | Q02880 | 2/20 | 0.45 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18824746 | 0.81 | NISCH (0.60) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL11285269 | 0.79 | NISCH (0.51) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL13830897 | 0.77 | NISCH (0.56) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL13831048 | 0.76 | NISCH (0.53) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL18824710 | 0.75 | NISCH (0.58) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL7486584 | 0.74 | NISCH (0.50) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL4066929 | 0.74 | NISCH (0.51) | NISCHGAATSHR | |
| SCHEMBL13830922 | 0.74 | NISCH (0.58) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL11273702 | 0.74 | NISCH (0.58) | NISCHGAATSHRTOP2ATOP2B | |
| SCHEMBL4822597 | 0.74 | NISCH (0.80) | NISCHGAATSHRTOP2ATOP2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012153768-A1 | MEDICINAL AGENT CONTAINING PYRMIDOBENZOTHIAZIN-6-IMINE DERIVATIVE OR SALT THEREOF FOR PREVENTION AND/OR TREATMENT OF VIRAL INFECTION | 富士フイルム株式会社 (JP) | 2012-11-15 | — | — | WO | disclosed |